1997 年至 2008 年西班牙胸腔积液中肺炎链球菌分离株的血清型分布和药敏情况。
Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008.
机构信息
Spanish Reference Pneumococcal Laboratory, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
出版信息
Antimicrob Agents Chemother. 2010 Dec;54(12):5387-90. doi: 10.1128/AAC.00217-10. Epub 2010 Oct 4.
Abstract
Trends in serotype incidence and susceptibility (1997 to 2008) of Spanish Streptococcus pneumoniae pleural isolates (n = 831) were explored. Penicillin (oral) nonsusceptibility rates and the incidence of 7-valent pneumococcal conjugate vaccine (PCV-7) serotypes showed decreasing trends (R(2) ≥ 0.600; P ≤ 0.002). The incidence of serotypes 1 and 19A showed increasing trends (R(2) ≥ 0.759; P < 0.001), with no trends for serotype 3. Serotypes 19A, 1, and 3 represented 85% of pediatric isolates in 2008. In serotype 19A, the penicillin nonsusceptibility rate was 82.4% in 2008, associated with amoxicillin and cefotaxime nonsusceptibility in 21.4% of isolates. Inclusion of these serotypes in new vaccines offers the broadest coverage.
摘要
研究了西班牙肺炎链球菌胸膜分离株（n = 831）血清型发生率和敏感性（1997 年至 2008 年）的变化趋势。青霉素（口服）不敏感率和 7 价肺炎球菌结合疫苗（PCV-7）血清型的发生率呈下降趋势（R²≥0.600；P≤0.002）。血清型 1 和 19A 的发生率呈上升趋势（R²≥0.759；P<0.001），而血清型 3 则没有趋势。2008 年，血清型 19A、1 和 3 占儿科分离株的 85%。在血清型 19A 中，2008 年青霉素不敏感率为 82.4%，其中 21.4%的分离株对阿莫西林和头孢噻肟不敏感。将这些血清型纳入新疫苗可提供最广泛的保护。
相似文献
1
Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008.
Antimicrob Agents Chemother. 2010 Dec;54(12):5387-90. doi: 10.1128/AAC.00217-10. Epub 2010 Oct 4.
2
Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009.
BMC Infect Dis. 2011 Sep 12;11:239. doi: 10.1186/1471-2334-11-239.
3
Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008.
Antimicrob Agents Chemother. 2011 May;55(5):2297-302. doi: 10.1128/AAC.01494-10. Epub 2011 Feb 22.
4
Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
Pediatr Infect Dis J. 2007 Jun;26(6):461-7. doi: 10.1097/INF.0b013e31805cdbeb.
5
Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.
J Korean Med Sci. 2017 Sep;32(9):1431-1439. doi: 10.3346/jkms.2017.32.9.1431.
6
Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine.
Antimicrob Agents Chemother. 2010 Jun;54(6):2696-8. doi: 10.1128/AAC.01594-09. Epub 2010 Mar 22.
7
Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Vaccine. 2012 Dec 31;30 Suppl 6:G37-40. doi: 10.1016/j.vaccine.2012.10.061.
8
Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.
Hum Vaccin Immunother. 2014;10(7):1866-73. doi: 10.4161/hv.28675.
9
Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.
Int J Antimicrob Agents. 2013 Nov;42(5):395-402. doi: 10.1016/j.ijantimicag.2013.07.017. Epub 2013 Sep 6.
10
Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
Pediatr Infect Dis J. 2010 Apr;29(4):294-300. doi: 10.1097/INF.0b013e3181c2a229.
引用本文的文献
1
The Alere BinaxNOW Pneumococcal Urinary Antigen Test: Diagnostic Sensitivity for Adult Pneumococcal Pneumonia and Relationship to Specific Serotypes.
J Clin Microbiol. 2018 Jan 24;56(2). doi: 10.1128/JCM.00787-17. Print 2018 Feb.
2
Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306.
PLoS One. 2012;7(8):e42595. doi: 10.1371/journal.pone.0042595. Epub 2012 Aug 13.
3
Cefditoren in upper and lower community-acquired respiratory tract infections.
Drug Des Devel Ther. 2011 Feb 9;5:85-94. doi: 10.2147/DDDT.S9499.
本文引用的文献
1
Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah.
J Clin Microbiol. 2010 Feb;48(2):520-5. doi: 10.1128/JCM.01200-09. Epub 2009 Dec 16.
2
Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
Pediatrics. 2010 Jan;125(1):26-33. doi: 10.1542/peds.2009-0184. Epub 2009 Nov 30.
3
Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccine.
J Antimicrob Chemother. 2009 Dec;64(6):1338-40. doi: 10.1093/jac/dkp376. Epub 2009 Oct 14.
4
Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.
J Antimicrob Chemother. 2009 Sep;64(3):507-10. doi: 10.1093/jac/dkp210. Epub 2009 Jun 17.
5
Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
J Antimicrob Chemother. 2008 Dec;62(6):1430-3. doi: 10.1093/jac/dkn413. Epub 2008 Sep 26.
6
Pediatric parapneumonic empyema, Spain.
Emerg Infect Dis. 2008 Sep;14(9):1390-7. doi: 10.3201/eid1409.071094.
7
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
Antimicrob Agents Chemother. 2008 Nov;52(11):4209-10. doi: 10.1128/AAC.00712-08. Epub 2008 Aug 25.
8
Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
Clin Infect Dis. 2008 Jan 15;46(2):174-82. doi: 10.1086/524660.
9
Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.
JAMA. 2007 Apr 25;297(16):1784-92. doi: 10.1001/jama.297.16.1784.
10
Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine.
Clin Microbiol Infect. 2006 Sep;12(9):867-72. doi: 10.1111/j.1469-0691.2006.1502_1.x.
Zotero 插件